Infliximab biosimilar-induced lupus nephritis: A case report.
Shidahara K, Katsuyama T, Hirose K, Matsumoto K, Nawachi S, Nakadoi T, Asano Y, Katayama Y, Miyawaki Y, Katsuyama E, Takano-Narazaki M, Matsumoto Y, Sada KE, Wada J.
Shidahara K, et al.
Mod Rheumatol Case Rep. 2023 Dec 29;8(1):74-76. doi: 10.1093/mrcr/rxad061.
Mod Rheumatol Case Rep. 2023.
PMID: 37902434
Renal biopsy showed lupus nephritis (ISN/RPS classification class IV + V). Treatment with the infliximab biosimilar was discontinued, and treatment with prednisolone, hydroxychloroquine and abatacept was started, resulting in clinical remission of lupus nephritis and RA. . …
Renal biopsy showed lupus nephritis (ISN/RPS classification class IV + V). Treatment with the infliximab biosimilar was discontinued, …